Clinical Trial Update: Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating melphalan, prednisone, and lenalidomide in newly diagnosed multiple myeloma completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-12-13